Come up with a name for your new list and we'll add to it:
Cold Genesys raised a round of funding on July 30, 2014. Investors include
Ally Bridge Group.
Cold Genesys is a clinical-stage immuno-oncology company focused on the development of oncolytic immunotherapies to combat cancer. In 2010, Cold Genesys acquired exclusive worldwide rights to develop …